Cancer Research UK logo.
SearchDonate
  • Search

A study of PDR001 alongside dabrafenib and trametinib for melanoma skin cancer

Overview

Cancer types:

Melanoma, Skin cancer

Status:

Closed

Phase:

Phase 3

Details

This study is looking at a new drug called PDR001. It is for people whose melanoma:

  • cannot be removed with surgery or has spread elsewhere in the body

  • cells have a change in a gene called BRAF

Recruitment start: 7 March 2017

Recruitment end: 6 June 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr. James Larkin

Supported by

Novartis

Last reviewed: 10 June 2018

CRUK internal database number: 14512

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.